Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Portal-Systemic Encephalopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT02086825
What this trial is testing

Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Who this might be right for
Hepatic Encephalopathy
NYU Langone Health
Post-approval studies (Phase 4)Study completedNCT03077217
What this trial is testing

Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy

Who this might be right for
Covert Hepatic Encephalopathy
Shanghai Changzheng Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT00364689
What this trial is testing

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Who this might be right for
Hepatic Encephalopathy
University of Miami 13
Large-scale testing (Phase 3)UnknownNCT00553423
What this trial is testing

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

Who this might be right for
Hepatocerebral EncephalopathyPortal-Systemic EncephalopathyEncephalopathy, Hepatic+1 more
Aga Khan University 128
Not applicableWithdrawnNCT03115697
What this trial is testing

High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.

Who this might be right for
Refractory Hepatic Encephalopathy
Institute of Liver and Biliary Sciences, India
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07528690
What this trial is testing

Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)

Who this might be right for
Hepatic EncephalopathyCirrhosis
VA Office of Research and Development 162
Post-approval studies (Phase 4)Study completedNCT00886925
What this trial is testing

Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Hospital Universitari Vall d'Hebron Research Institute 56
Large-scale testing (Phase 3)Study completedNCT00433368
What this trial is testing

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Aga Khan University 108
Not applicableEnded earlyNCT04940416
What this trial is testing

Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease

Who this might be right for
CirrhosisHepatic Encephalopathy
Stanford University 48
Post-approval studies (Phase 4)UnknownNCT05788627
What this trial is testing

Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyChronic Liver Disease
Khyber Medical College, Peshawar 100
Early research (Phase 1)Study completedNCT03152188
What this trial is testing

Oral Fecal Transplant in Cirrhosis

Who this might be right for
Hepatic EncephalopathyCirrhosis, Liver
Virginia Commonwealth University 20
Testing effectiveness (Phase 2)Study completedNCT02017119
What this trial is testing

Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients

Who this might be right for
CirrhosisHepatic Encephalopathy
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40
Not applicableUnknownNCT05206487
What this trial is testing

Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME)

Who this might be right for
Hepatic Encephalopathy
University Hospital, Toulouse 30
Not applicableEnded earlyNCT02439307
What this trial is testing

Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial

Who this might be right for
Small Intestinal Bacterial OvergrowthLiver Cirrhosis
Coordinación de Investigación en Salud, Mexico 11
Not applicableUnknownNCT03825848
What this trial is testing

The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy

Who this might be right for
Portal HypertensionHepatic Encephalopathy
Shanghai Zhongshan Hospital 130
Not applicableNot Yet RecruitingNCT06679868
What this trial is testing

Role of ALBI Score and Sarcopenia As Prognostic Predictors Among Hospitalized Cirrhotic Patients With Hepatic Encephalopathy

Who this might be right for
Liver Cirrhosis
Assiut University 106
Not applicableUnknownNCT05466669
What this trial is testing

Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis

Who this might be right for
Hepatic EncephalopathyLiver Cirrhosis
Johannes Gutenberg University Mainz 83
Testing effectiveness (Phase 2)Study completedNCT01069133
What this trial is testing

Study of Rifaximin in Minimal Hepatic Encephalopathy

Who this might be right for
Minimal Hepatic Encephalopathy
Hunter Holmes Mcguire Veteran Affairs Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT06987968
What this trial is testing

See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis
Genfit 3
Post-approval studies (Phase 4)Looking for participantsNCT06808074
What this trial is testing

Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis

Who this might be right for
Hepatic EncephalopathyCirrhosisVentilator Associated Pneumonia (VAP)
Asian Institute of Gastroenterology, India 162
Next Page